List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 699,
    "next": "http://api.gregory-ms.com/trials/?page=2",
    "previous": null,
    "results": [
        {
            "trial_id": 364489,
            "title": "A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Satisfaction in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Treated with Subcutaneous...",
            "summary": "<p>EudraCT Number: 2015-000922-12<br />Sponsor Protocol Number: TV44400-CNS-40083<br />Sponsor Name: Teva Pharmaceutical Industries, Ltd<br />Start Date: 2016-01-04<br />Medical condition: Relapsing-Remitting Multiple Sclerosis (RRMS)<br />Disease: <br />Version: 18.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/BE\">BE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/AT\">AT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/DE\">DE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/IE\">IE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/PL\">PL</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/FI\">FI</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/ES\">ES</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/HR\">HR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/FR\">FR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/IT\">IT</a> (Completed)</p>",
            "published_date": null,
            "discovery_date": "2022-08-17T12:50:07.394575Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000922-12",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 364474,
            "title": "The Effect of Backward Walking Training on Balance, Gait and Functional Mobility in Patients With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: Exercise training<br /><b>Sponsors</b>:    Saglik Bilimleri Universitesi;   Ankara University<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-17T12:00:00Z",
            "discovery_date": "2022-08-17T12:50:07.035462Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05505383?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 364469,
            "title": "Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years",
            "summary": "<p>EudraCT Number: 2014-005003-24<br />Sponsor Protocol Number: 109MS202<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2015-06-01<br />Medical condition: Relapsing-Remitting Multiple Sclerosis<br />Disease: <br />Version: 17.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10029205<br />Term: Nervous system disorders<br />Level: SOC<br />Version: 17.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Children, Adolescents, Under 18<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005003-24/LV\">LV</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005003-24/DE\">DE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005003-24/CZ\">CZ</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005003-24/BG\">BG</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005003-24/PL\">PL</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005003-24/BE\">BE</a> (Completed)</p>",
            "published_date": null,
            "discovery_date": "2022-08-17T12:15:16.361992Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-005003-24",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 363697,
            "title": "A Measurement Study of TIS-modNV and AccuGait Force Platform in People With MS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Nordlandssykehuset HF;   Nord University;   Helse Nord<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-16T12:00:00Z",
            "discovery_date": "2022-08-16T11:20:12.715644Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05503628?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 363692,
            "title": "Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Power Life Sciences Inc.<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-16T12:00:00Z",
            "discovery_date": "2022-08-16T11:20:12.701964Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05503524?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 363672,
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "summary": "<p>EudraCT Number: 2012-002714-40<br />Sponsor Protocol Number: RPC01-201<br />Sponsor Name: Receptos, Inc.<br />Start Date: 2013-05-09<br />Medical condition: RELAPSING MULTIPLE SCLEROSIS<br />Disease: <br />Version: 14.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10048393<br />Term: Multiple sclerosis relapse<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/IT\">IT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/BE\">BE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/ES\">ES</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/HU\">HU</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/BG\">BG</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/GR\">GR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/GB\">GB</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/SK\">SK</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/HR\">HR</a> (Completed)</p>",
            "published_date": null,
            "discovery_date": "2022-08-16T10:15:16.351517Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-002714-40",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 362944,
            "title": "Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Device: Transcutaneous electrical nerve stimulation<br /><b>Sponsor</b>:    University of Colorado, Boulder<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-15T12:00:00Z",
            "discovery_date": "2022-08-15T10:45:08.852519Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05500963?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 361659,
            "title": "Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosis",
            "summary": "<p>EudraCT Number: 2021-003677-66<br />Sponsor Protocol Number: RESTORE<br />Sponsor Name: Amsterdam University Medical Center<br />Start Date: 2022-02-14<br />Medical condition: Multiple sclerosis (MS)\nInternuclear ophthalmoparesis (INO)<br />Disease: <br />Version: 21.0<br />SOC Term: 100000004852<br />Classification Code: 10080865<br />Term: Multiple sclerosis lesion<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-003677-66/NL\">NL</a> (Ongoing)</p>",
            "published_date": null,
            "discovery_date": "2022-08-13T12:42:11.120527Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-003677-66",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 361454,
            "title": "A 12-month, Open-label, Prospective, Multicenter, Interventional, Single-arm Study Assessing the Efficacy and Safety of Ofatumumab 20 mg Subcutaneous (s.c.) Injection in Relapsing Multiple Sclerosis (RMS) Patients in China",
            "summary": null,
            "published_date": null,
            "discovery_date": "2022-08-13T04:12:37.212398Z",
            "link": "https://www.novartis.com//clinicaltrials/study/nct05199571",
            "source": "Novartis",
            "relevant": null
        },
        {
            "trial_id": 360541,
            "title": "A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Intervention</b>:    Drug: Mitoxantrone Hydrochloride Liposome Injection<br /><b>Sponsor</b>:    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-11T12:00:00Z",
            "discovery_date": "2022-08-11T12:55:08.944779Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05496894?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        }
    ]
}